Does RIFAMPIN Cause Excessive granulation tissue? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Excessive granulation tissue have been filed in association with RIFAMPIN (Rifampin). This represents 0.0% of all adverse event reports for RIFAMPIN.
5
Reports of Excessive granulation tissue with RIFAMPIN
0.0%
of all RIFAMPIN reports
1
Deaths
3
Hospitalizations
How Dangerous Is Excessive granulation tissue From RIFAMPIN?
Of the 5 reports, 1 (20.0%) resulted in death, 3 (60.0%) required hospitalization.
Is Excessive granulation tissue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIFAMPIN. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does RIFAMPIN Cause?
Drug ineffective (1,238)
Drug reaction with eosinophilia and systemic symptoms (1,049)
Drug interaction (735)
Pyrexia (735)
Acute kidney injury (684)
Drug-induced liver injury (684)
Off label use (640)
Condition aggravated (597)
Nausea (572)
Paradoxical drug reaction (570)
What Other Drugs Cause Excessive granulation tissue?
CARBIDOPA\LEVODOPA (117)
ADALIMUMAB (38)
BACLOFEN (31)
ZOLEDRONIC ACID (29)
ZOMETA (27)
AREDIA (21)
METHOTREXATE (19)
RITUXIMAB (13)
BECAPLERMIN (11)
PAMIDRONATE (11)
Which RIFAMPIN Alternatives Have Lower Excessive granulation tissue Risk?
RIFAMPIN vs RIFAMYCIN
RIFAMPIN vs RIFAPENTINE
RIFAMPIN vs RIFAXIMIN
RIFAMPIN vs RILMENIDINE
RIFAMPIN vs RILONACEPT